EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modeling cystic fibrosis patient prognosis: Nomograms to predict lung transplantation and survival prior to highly effective modular therapy

Annalisa V Piccorelli iD, Jerry A Nick

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0292568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Annalisa V Piccorelli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biostatistics, Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States of America. Hauptthemen laut MEDLINE: Cystic Fibrosis, Lung Transplantation, Nomograms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The duration of time a person with cystic fibrosis (pwCF) spends on the lung transplant waitlist is dependent on waitlist and post-transplant survival probabilities and can extend up to 2 years. Understanding the characteristics involved with lung transplant and survival prognoses may help guide decision making by the patient, the referring CF Center and the transplant team.

Methods

This study seeks to identify clinical predictors of lung transplant and survival of individuals with CF using 29,847 subjects from 2003–2014 entered in the Cystic Fibrosis Foundation Patient Registry (CFFPR).

Results

Predictors significant (p ≤ 0.05) in the final logistic regression model predicting probability of lung transplant/death were: FEV 1 (% predicted), BMI, age of diagnosis, age, number of pulmonary exacerbations, race, sex, CF-related diabetes (CFRD), corticosteroid use, infections with B . cepacia , P . aeruginosa , S . aureus , MRSA, pancreatic enzyme use, insurance status, and consecutive ibuprofen use for at least 4 years. The final Cox regression model predicting time to lung transplant identified these predictors as significant FEV 1 (% predicted), BMI, age of diagnosis, age, number of pulmonary exacerbations, race, sex, CF-related diabetes (CFRD), corticosteroid use, infections with B . cepacia , P . aeruginosa , S . aureus , MRSA, pancreatic enzyme use, and consecutive ibuprofen use for at least 4 years. The concordance indices were 0.89 and 0.92, respectively.

Conclusions

The models are translated into nomograms to simplify investigation of how various characteristics relate to lung transplant and survival prognosis individuals with CF not receiving highly effective CFTR modulator therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisLung TransplantationNomogramsHumansMaleFemaleAdultPrognosisAdolescentChildYoung AdultMiddle AgedRegistries

Autor:innen und Institutionen

  • Division of Biostatistics, Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States of America.
  • Department of Medicine, National Jewish Health, Denver, CO, United States of America.

ORCID-Profile: Annalisa V Piccorelli

Zitieren

APA

Piccorelli, A. V., & Nick, J. A. (2024). Modeling cystic fibrosis patient prognosis: Nomograms to predict lung transplantation and survival prior to highly effective modular therapy. PLOS ONE. https://doi.org/10.1371/journal.pone.0292568

Vancouver

Piccorelli AV, Nick JA. Modeling cystic fibrosis patient prognosis: Nomograms to predict lung transplantation and survival prior to highly effective modular therapy. PLOS ONE. 2024. doi:10.1371/journal.pone.0292568

BibTeX
@article{Piccorelli2024,
  author = {Piccorelli, Annalisa V and Nick, Jerry A},
  title = {Modeling cystic fibrosis patient prognosis: Nomograms to predict lung transplantation and survival prior to highly effective modular therapy},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0292568}
}
Kostenlos starten →